Component

Nrf2-target gene expression in COPD airway cells

Nrf2-target gene expression in COPD airway cells. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Neither oral dose consistently induced the measured Nrf2 target genes despite detectable plasma metabolites.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/sulforaphane-research/27832073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003", "start_char": 0, "end_char": 1709, "text_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003"}
    experimental_model
    Randomized double-blind placebo-controlled phase 2 trial
    exposure
    25 or 150 micromol sulforaphane daily for four weeks
    limitations
    Absorption was documented; cell-based target engagement cannot be assumed after oral dosing in patients.
    nutrient_topic
    Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
    organism
    Human, 89 COPD patients
    plain_language
    Reaching the bloodstream did not guarantee the intended lung-cell response.
    primary_references
    [sulforaphane-p27832073] Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. (2016). https://pubmed.ncbi.nlm.nih.gov/27832073/ DOI: 10.1371/journal.pone.0163716
    tissue_or_cell_type
    Alveolar macrophages, bronchial epithelium and pulmonary function

    Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1087–1098

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled phase 2 trial · source_derived_draft · unverified_draft

    ### sulforaphane-copd-target-null Neither oral dose consistently induced the measured Nrf2 target genes despite detectable plasma metabolites. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Reaching the bloodstream did not guarantee the intended lung-cell response. organism: Human, 89 COPD patients tissue_or_cell_type: Alveolar macrophages, bronchial epithelium and pulmonary function experimental_model: Randomized double-blind placebo-controlled phase 2 trial limitations: Absorption was documented; cell-based target engagement cannot be assumed after oral dosing in patients. exposure: 25 or 150 micromol sulforaphane daily for four weeks evidence_span: {"source_cache": "artifacts/sulforaphane-research/27832073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003", "start_char": 0, "end_char": 1709, "text_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003"} [sulforaphane-p27832073] Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. (2016). https://pubmed.ncbi.nlm.nih.gov/27832073/ DOI: 10.1371/journal.pone.0163716
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards